{"task_id": "3b128faaabc1c6c4", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 419/464)", "text": "t prophylaxis\n412\nInfectious Diseases in Pregnancy\n\n--- Page 434 ---\nHUMAN IMMUNODEFICIENCY VIRUS (HIV)\nANTEPARTUM CARE\ndetermine HIV symptoms,\ninfections, immunization status, and perform ophthal\nmologic examination if CD4 <50/mm3. Baseline test\ning include CBCD, lytes, urea, Cr, AST, ALT, ALP, bilir\nubin, CD4 count, viral load, TB skin test, toxoplasma,\nVDRL, pap smear, cervical swabs for gonorrhea and\nchlamydia, CMV, HBV, and HCV serologies. Counsel\nregarding perinatal transmission (30% without treat\nment, <1% with optimal and effective combination\ntherapy), contraceptive use during pregnancy (con\ndoms), and mode of delivery. If on HAART already,\ncontinue as combination therapy which should con\ntain AZT. For pregnant women not already on HAART,\nconsider zidovudine from 2nd trimester onwards. Pro\nphylaxis for opportunistic infections same as in non\npregnancy patients. Amniocentesis or other invasive\nprocedures may increase vertical transmission risk\nINTRAPARTUM CARE\nupon onset of labour or rup\nture of membranes, give zidovudine 2 mg/kg IV over\n1 h, then 1 mg/kg until delivery (even if on HAART\nalready). For cesarean section, start infusion at least 3 h\nbefore procedure. Consider use of cesarean delivery if\nviral load >1000/mL. Avoid invasive monitoring, use\nof instruments to assist delivery, and prolonged inter\nval between rupture of membranes and delivery\nPOSTPARTUM CARE\ntreat newborn with zidovu\ndine for 6 weeks, to be followed by PJP prophylaxis.\nDetermine HIV status at 1 2 days, 2 weeks, 1 2\nmonths, and 3 6 months. Avoid breast feeding.\nEnsure good support system for mother. Counsel\nregarding contraceptive use\nNEJM 2002 346:24\nTORCHES INFECTIONS\nINFECTIONS ASSOCIATED WITH BIRTH DEFECTS\nwTORCHESw\nTOxoplasma, Rubella, CMV, HErpes,\nand Syphilis infections during pregnancy are associated\nwith birth defects\nTUBERCULOSIS\nMANAGEMENT\ntreat patient as risk of infection to\nfetus is greater than risk of medications. Use isoniazid,\nrifampin, and ethambutol for 9 months minimum.\nBreastfeeding is safe. Pyridoxine 25 mg PO daily is\nrecommended for all pregnant or breastfeeding\nwomen taking isoniazid\nANTIBIOTICS\nACCEPTABLE\npenicillins,\ncephalosporins,\nazi\nthromycin, vancomycin, metronidazole, clindamy\ncin, erythromycin (except erythromycin estolate),\nnitrofurantoin\n(caution\nas\nrisk\nof\nhemolytic\nanemia), and acyclovir. Consider trimethoprim\nsulfamethoxazole (avoid in first trimester but use\nwith folate if no other alternatives) and amino\nglycosides\n(except\nstreptomycin)\nin\nsome\ncircumstances\nAVOID\ntetracyclines, streptomycin, fluoroquinolones\nRelated Topics\nHIV (p. 259)\nTuberculosis (p. 250)\nUrinary Tract Infections (p. 244)\nEndocrine Disorders in Pregnancy\nDIABETES IN PREGNANCY\nRISK FACTORS FOR GESTATIONAL DIABETES\nprevious history of gestational diabetes, prior delivery\nof macrosomic infant, ethnic group (Aboriginal, Hispa\nnic, Asian, African), maternal age \u000335, obesity, PCOS,\npolyhydramnios, multiple gestation, fetal macrosomia\n(>4000 g or >90th percentile) or unexplained still\nbirth, family history of diabetes, corticosteroid use\nDIAGNOSIS OF GESTATIONAL DIABETES\n\u0004 Step 1: Gestational Diabetes Screen (GDS)\n50 g oral glucose and draw blood after 1 h\n\u0004 If blood glucose \u000310.3 mmol/L [\u0003185 mg/dL],\ndiagnosis of GDM can be made\n\u0004 If blood, glucose \u00037.8 mmol/L [\u0003140 mg/dL],\nperform 2 hr OGTT\n\u0004 If blood glucose is <7.8 mmol/L [<140 mg/dL],\nthen no GDM but re test if continued at high\nrisk or high suspicion (e.g. macrosomia, poly\nhydramnios)\nDIABETES IN PREGNANCY (CONT\u2019D)\n\u0004 Step 2: 2 h Oral Glucose Tolerance Test\n(OGTT) 75 g glucose after overnight fast\n\u0004 Abnormal if fasting blood glucose\n\u00035.3 mmol/L [\u000395 mg/dL]\n\u0004 Or1 hbloodglucose\u000310.6mmol/L[\u0003190 mg/dL]\n\u0004 Or 2 hour blood glucose \u00038.6 mmol/L\n[\u0003155 mg/dL]\n\u0004 Step 3: Diagnosis based on OGTT\n\u0004 If 1 value abnormal, then impaired glucose\ntolerance of pregnancy (IGTP)\n\u0004 If \u00032 values abnormal, then GDM\nMONITORING\nmonitor blood glucose ac all meals\nfor type 1 diabetics (goal <5.3 mmol/L [<95 mg/dL]),\n1h post all meals (goal <7.8 mmol/L [<140 mg/dL]),\nand qhs (goal <6 mmol/L [<108 mg/dL]). Hypergly\ncemia during the 1st trimester is a teratogen. Check\nurine ketones every morning\nEndocrine Disorders in Pregnancy\n413", "text_length": 4216, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 419/464)", "type": "chunk", "chunk_index": 418, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.824925", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.825664", "status": "pending"}